Lifecore Biomedical, Inc.

Historical 13F Holders

Symbol
LFCR
CUSIP
514766104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 514766104 since 12/18/2024, newest first.

Filer % of Class Filed
Wynnefield Partners Small Cap Value, L.P. I 13D/A Amendment 11
14.3% 9/29/2026
Event 9/27/2026
Legion Partners Asset Management, LLC 13D/A Amendment 11
17.3% 9/28/2026
Event 9/27/2026
BlackRock, Inc. 13G 5.4% 7/29/2026
Event 6/30/2026
22NW Fund, LP 13D/A Amendment 8
6.7% 7/2/2026
Event 6/30/2026
Legion Partners Asset Management, LLC 13D/A Amendment 10
17.1% 7/2/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 1 4.98% 4/27/2026
Event 3/31/2026
BlackRock, Inc. 13G 5.1% 1/21/2026
Event 12/31/2025
BlackRock, Inc. 13G/A Amendment 1 4.9% 10/17/2025
Event 9/30/2025
BlackRock, Inc. 13G 5.0%
Checked 5% or less
7/17/2025
Event 6/30/2025
22NW Fund, LP 13D/A Amendment 7
7.5% 5/29/2025
Event 5/27/2025
Greenhaven Road Investment Management, L.P. 13G/A Amendment 2
9.8% 2/14/2025
Event 12/31/2024
Greenhaven Road Investment Management, L.P. 13G/A Amendment 1
7.8% 2/14/2025
Event 12/31/2023
David Capital Partners, LLC 13G/A Amendment 1
4.9% 2/5/2025
Event 12/31/2024
22NW Fund, LP 13D/A Amendment 6
11.1% 12/26/2024
Event 12/23/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 2.05 k $13.5 k
2026 Q2 103 25.4 M $134 M
2026 Q1 109 25.1 M $112 M
2025 Q4 109 24.8 M $226 M
2025 Q3 103 24.3 M $199 M
2025 Q2 90 24.8 M $222 M
2025 Q1 89 24.5 M $190 M
2024 Q4 79 24.8 M $202 M
2024 Q3 86 20.7 M $117 M
2024 Q2 83 21.1 M $123 M
2024 Q1 87 23.1 M $123 M
2023 Q4 86 22.0 M $136 M
2023 Q3 79 22.0 M $133 M
2023 Q2 87 19.9 M $174 M
2023 Q1 87 23.1 M $83.5 M
2022 Q4 99 25.2 M $163 M
2022 Q3 88 24.8 M $220 M
2022 Q2 91 25.3 M $252 M
2022 Q1 101 25.7 M $279 M
2021 Q4 101 25.9 M $288 M
2021 Q3 94 25.5 M $235 M
2021 Q2 99 26.0 M $292 M
2021 Q1 95 26.0 M $275 M
2020 Q4 99 28.8 M $312 M
2020 Q3 99 27.3 M $265 M
2020 Q2 97 26.8 M $213 M
2020 Q1 91 27.1 M $235 M
2019 Q4 97 27.9 M $315 M
2019 Q3 106 26.5 M $288 M
2019 Q2 102 27.5 M $258 M
2019 Q1 95 26.5 M $326 M
2018 Q4 91 26.2 M $310 M
2018 Q3 94 25.9 M $370 M
2018 Q2 93 25.1 M $374 M
2018 Q1 91 26.4 M $344 M
2017 Q4 91 25.8 M $325 M
2017 Q3 97 25.8 M $334 M
2017 Q2 97 25.3 M $376 M
2017 Q1 89 25.1 M $302 M
2016 Q4 95 24.7 M $341 M
2016 Q3 93 25.0 M $336 M
2016 Q2 97 25.7 M $277 M
2016 Q1 95 25.1 M $263 M
2015 Q4 112 24.4 M $289 M
2015 Q3 114 24.0 M $280 M
2015 Q2 108 24.4 M $353 M
2015 Q1 104 24.2 M $339 M
2014 Q4 112 24.3 M $336 M
2014 Q3 109 24.6 M $299 M
2014 Q2 104 24.3 M $304 M
2014 Q1 101 23.7 M $265 M